HEXO Corp is proud to launch its line of vape products to both adult-use and medical consumers, across Canada.
HEXO Corp is proud to announce that it has launched medical cannabis products in Israel through a 24-month agreement with leading Israeli medical cannabis company, Breath of Life International Ltd. (“BOL”).
HEXO Corp. today announced the final closing of its previously announced early conversion option (the “Early Conversion Option”) in respect of $29.86 million aggregate principal amount of its outstanding $70 million aggregate principal amount of 8% unsecured convertible debentures maturing December 5, 2022 (the “Debentures”).
ANNUAL PRODUCTION CAPACITY
POINTS OF QUALITY CONTROL
Want to keep in touch? We’ll send you our latest updates. You can unsubscribe at any time.